Investing in Customer Loyalty: The Strategy Behind the ACSI ETF

The ETF tracks the American Customer Satisfaction Investable Index. This benchmark employs proprietary metrics to evaluate ...

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

DURHAM, N.C., March 28, 2026 (GLOBE NEWSWIRE) -- Priovant Therapeutics, a clinical-stage biotechnology company focused on developing targeted therapeutics in autoimmune disease, announced today the ...

2026: The Pivotal Year for Prime Medicine's Clinical Ambitions

The biotechnology firm Prime Medicine is approaching what could be its most definitive period. Following its 2025 annual results, the company is shifting its strategic emphasis from initial clinical ...

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

MoonLake Immunotherapeutics (NASDAQ: MLTX) (MoonLake or the Company), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announces ...

Black Bird Biotech Completes Strategic Rebranding and Shifts Focus

The company formerly known as Digital Development Partners has now officially completed its rebranding to Black Bird Biotech. This finalizes a significant corporate transformation, shifting investor ...

ServiceNow Expands Strategic Alliances to Fortify AI Ecosystem

ServiceNow is accelerating the development of its artificial intelligence ecosystem through a series of strategic partnerships announced in quick succession. The collaborations focus on enhancing the ...

Australian Vanadium Advances Major Energy Storage Ambitions

Australian Vanadium Ltd. is making significant strides toward establishing an integrated supply chain in Western Australia. A key development is the company's exclusive alliance with Japan's Sumitomo ...

Hims & Hers Health Aktie: Weight-Watchers-Offensive erhöht den Druck

New York (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von TD Cowen: Die Analysten von TD Cowen stufen die Aktie von Hims & Hers Health Inc. (ISIN: US4330001060, WKN: A2QMYY, Ticker-Symbol: ...
Aktien Check

XFRA: AU3CB0330777: Wiederaufnahme/Resumption

XFRA: AU3CB0330777: Wiederaufnahme/Resumption () | aktiencheck.de FOLGENDE (S) INSTRUMENT (E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING ...

Bayer Aktienanalyse: 12. Mai könnte für neuen Schwung sorgen - Starke Zahlen und Glyphosat-Verhandlung im Blick

Charles Pitman-King von Barclays sieht hier die Basis für eine mögliche Neubewertung der Bayer Aktie. Besonders wichtig ist dabei die Erwartung, dass Bayer am 12. Mai ein starkes EBITDA vor Sondereffe ...

Koenig & Bauer Aktie: Starker Jahresstart in Aussicht gestellt

Hamburg (www.aktiencheck.de) - Koenig & Bauer-Aktienanalyse der Montega AG: Patrick Speck, Analyst der Montega AG, rät in einer aktuellen Aktienanalyse weiterhin zum Kauf der Aktie der Koenig & Bauer ...
Aktien Check

Mercedes-Benz Q2 2025 Quartalszahlen: Milliarden-Cashflow, aber EBIT bricht um 50% ein!

Die Mercedes-Benz Group AG (ISIN: DE0007100000, WKN: 710000, Ticker-Symbol: MBG, NASDAQ OTC-Symbol: DDAIF) hat im zweiten Quartal 2025 trotz erheblicher geopolitischer Unsicherheiten und ...